Back

Interruption of oral anticoagulants after atrial fibrillation catheter ablation: the importance of risk stratification

European Heart Journal

23 January 2024
Organised by: Logo
Read full article
ESC Journals ARRHYTHMIAS AND DEVICE THERAPY Arrhythmias, General

Contributors

Stephen Brienesse
Stephen Brienesse

Author

Rod Passman
Rod Passman

Author

Ben Freedman
Ben Freedman

Author

Heart Research Institute Sydney , Australia

You may be interested in
thumbnail
Congress Presentation
Exploring the feasibility of discontinuing oral anticoagulant therapy in post-ablation atrial fibrillation patients with low stroke risk: a conceptual inquiry
1 April 2025
thumbnail
Webinar
Key updates from the EHRA/HRS/APHRS/LAHRS 2024 Expert Consensus Statement on Atrial Fibrillation Ablation
10 February 2025
thumbnail
Congress Session
Stroke and bleeding risk in atrial fibrillation: walking the tight rope
25 August 2023
thumbnail
Congress Presentation
Uninterrupted trumps interrupted vitamin k antagonists as peri-atrial fibrillation ablation strategy - a network meta-analysis of safety in more than 25000 patients
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources